Q3-osavuosiraportti
UUTTA
7 päivää sitten‧28 min
Tarjoustasot
First North Sweden
Määrä
Osto
1 624
Myynti
Määrä
35 907
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 624 | - | - | ||
| 5 000 | - | - | ||
| 13 000 | - | - | ||
| 400 | - | - | ||
| 693 | - | - |
Ylin
0,287VWAP
Alin
0,272VaihtoMäärä
0,1 466 483
VWAP
Ylin
0,287Alin
0,272VaihtoMäärä
0,1 466 483
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 6.11. | |
| 2025 Ylimääräinen yhtiökokous | 27.10. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 12.5. |
Datan lähde: Millistream, Quartr
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·3 päivää sitten · MuokattuRHT is a real dark horse right now that can truly become a total game changer for Acarix. The good thing is, as you know, that the application is already complete and an answer is expected by the end of December. Some clipped quotes from the website with information about RHT: "Spark the growth of innovative care models to improve health outcomes" "Foster use of innovative technologies that promote efficient care delivery" "Developing projects that support innovative models of care that include value-based care arrangements" This really fits perfectly with CadScore, which can offer economic & affordable diagnostics specifically for rural areas with lower budgets where cardiologists are often lacking, etc. Quote Aamir: "Fitting to the T, we are the definition of what they are trying to do". I can only agree, it doesn't feel like a long shot but rather that it couldn't be stranger if Acarix doesn't get a piece of that $50 billion pie, which, as mentioned, would truly be perfect timing now that things are really starting to look promising. This, which is just one possibility, combined with Aamir's drive... the stock is ridiculously undervalued!? Perhaps it's not so strange that it has taken a long time to get here, but history has little to do with the future as it looks now.- ·7.11. · MuokattuHas RHS, which Aamir talks a lot about in the presentation, been discussed here yet? Talk about it fitting Acarix 100% Rural Health Transformation refers to a federal program to revitalize rural healthcare through a $50 billion investment authorized by the One Big Beautiful Bill Act. The program aims to strengthen rural health infrastructure by funding state-designed plans that focus on strategic goals such as improving access to care, developing the healthcare workforce, promoting innovation and preventative health, and expanding technology. States submitted applications to the Centers for Medicare & Medicaid Services (CMS) for funding, with the application period closing on November 5, 2025. Awards are expected to be announced by December 31, 2025.
- ·6.11. · MuokattuAamir works extremely hard with 100% commitment and seems to be doing most things right, while also being heavily invested in the company himself. If it continues in the right direction at this pace, this will turn out really well quite soon. With halved cash burn and increasing revenues, liquid funds will last until mid-2026, and just as Aamir says, this ensures that potential new financing can be arranged then with good terms. The Rural Health Grant also sounds clearly interesting and is truly a perfect match for Casdscore. I find it hard to understand today's mild reaction!
·7.11. · MuokattuI have three points: 1) The Q2 report was probably not very good - at least not financially. Many investors may be concerned that the Q3 figures are a one-off driven by MENA sales, and will want to see more consistency before they truly enter the case. 2) Concerns about further dilution in 2026 and/or new costs related to the new innovations Acarix is working on. 3) Financial reports are pouring out these days - including major market fluctuations. Acarix is probably not a top priority in many places, so maybe things just need to settle down? I can certainly say yes to all three points - I just need to figure out if now is the time to put more money into Acarix.·7.11.1. Nothing says that MENA cannot increase both in the short and long term. 22 new CS in the USA in just one quarter is certainly not to be underestimated. 2. There are currently approximately 21 MSEK in liquid assets. With a cash burn of 2.5-3 MSEK / month, that's enough well into 2026. And if revenues continue to increase on top of that... 3. True, it would be sensible with some AI-Tech bubble money transferred to neglected MedTech now!! Overall, Aamir is really holding onto the money while doing most things right!! It is undoubtedly moving in the right direction. 
·6.11.Analysis firm Redeye has this comment on today's Q3 report, including that they expect a 5-10 % increase in the share today due to the Q3 result : Acarix (Q3 Initial take): Record sales and improved OPEX Research Note 2025-11-06 08:50 Redeye provides its initial take on Acarix’s Q3 report, which showed record quarterly sales driven by the company’s first order and entry into the MENA region, as well as continued momentum in the US. The company also demonstrated improved cost efficiency following the implementation of its cost-saving initiatives, resulting in OPEX coming in better than our estimates. We expect a positive share price reaction of approximately 5–10% today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Q3-osavuosiraportti
UUTTA
7 päivää sitten‧28 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 päivää sitten · MuokattuRHT is a real dark horse right now that can truly become a total game changer for Acarix. The good thing is, as you know, that the application is already complete and an answer is expected by the end of December. Some clipped quotes from the website with information about RHT: "Spark the growth of innovative care models to improve health outcomes" "Foster use of innovative technologies that promote efficient care delivery" "Developing projects that support innovative models of care that include value-based care arrangements" This really fits perfectly with CadScore, which can offer economic & affordable diagnostics specifically for rural areas with lower budgets where cardiologists are often lacking, etc. Quote Aamir: "Fitting to the T, we are the definition of what they are trying to do". I can only agree, it doesn't feel like a long shot but rather that it couldn't be stranger if Acarix doesn't get a piece of that $50 billion pie, which, as mentioned, would truly be perfect timing now that things are really starting to look promising. This, which is just one possibility, combined with Aamir's drive... the stock is ridiculously undervalued!? Perhaps it's not so strange that it has taken a long time to get here, but history has little to do with the future as it looks now.
- ·7.11. · MuokattuHas RHS, which Aamir talks a lot about in the presentation, been discussed here yet? Talk about it fitting Acarix 100% Rural Health Transformation refers to a federal program to revitalize rural healthcare through a $50 billion investment authorized by the One Big Beautiful Bill Act. The program aims to strengthen rural health infrastructure by funding state-designed plans that focus on strategic goals such as improving access to care, developing the healthcare workforce, promoting innovation and preventative health, and expanding technology. States submitted applications to the Centers for Medicare & Medicaid Services (CMS) for funding, with the application period closing on November 5, 2025. Awards are expected to be announced by December 31, 2025.
- ·6.11. · MuokattuAamir works extremely hard with 100% commitment and seems to be doing most things right, while also being heavily invested in the company himself. If it continues in the right direction at this pace, this will turn out really well quite soon. With halved cash burn and increasing revenues, liquid funds will last until mid-2026, and just as Aamir says, this ensures that potential new financing can be arranged then with good terms. The Rural Health Grant also sounds clearly interesting and is truly a perfect match for Casdscore. I find it hard to understand today's mild reaction!·7.11. · MuokattuI have three points: 1) The Q2 report was probably not very good - at least not financially. Many investors may be concerned that the Q3 figures are a one-off driven by MENA sales, and will want to see more consistency before they truly enter the case. 2) Concerns about further dilution in 2026 and/or new costs related to the new innovations Acarix is working on. 3) Financial reports are pouring out these days - including major market fluctuations. Acarix is probably not a top priority in many places, so maybe things just need to settle down? I can certainly say yes to all three points - I just need to figure out if now is the time to put more money into Acarix.·7.11.1. Nothing says that MENA cannot increase both in the short and long term. 22 new CS in the USA in just one quarter is certainly not to be underestimated. 2. There are currently approximately 21 MSEK in liquid assets. With a cash burn of 2.5-3 MSEK / month, that's enough well into 2026. And if revenues continue to increase on top of that... 3. True, it would be sensible with some AI-Tech bubble money transferred to neglected MedTech now!! Overall, Aamir is really holding onto the money while doing most things right!! It is undoubtedly moving in the right direction.
- ·6.11.Analysis firm Redeye has this comment on today's Q3 report, including that they expect a 5-10 % increase in the share today due to the Q3 result : Acarix (Q3 Initial take): Record sales and improved OPEX Research Note 2025-11-06 08:50 Redeye provides its initial take on Acarix’s Q3 report, which showed record quarterly sales driven by the company’s first order and entry into the MENA region, as well as continued momentum in the US. The company also demonstrated improved cost efficiency following the implementation of its cost-saving initiatives, resulting in OPEX coming in better than our estimates. We expect a positive share price reaction of approximately 5–10% today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
1 624
Myynti
Määrä
35 907
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 624 | - | - | ||
| 5 000 | - | - | ||
| 13 000 | - | - | ||
| 400 | - | - | ||
| 693 | - | - |
Ylin
0,287VWAP
Alin
0,272VaihtoMäärä
0,1 466 483
VWAP
Ylin
0,287Alin
0,272VaihtoMäärä
0,1 466 483
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 6.11. | |
| 2025 Ylimääräinen yhtiökokous | 27.10. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 12.5. |
Datan lähde: Millistream, Quartr
Q3-osavuosiraportti
UUTTA
7 päivää sitten‧28 min
Uutiset ja analyysit
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
| 2025 Q4-osavuosiraportti | 12.2.2026 |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3-osavuosiraportti | 6.11. | |
| 2025 Ylimääräinen yhtiökokous | 27.10. | |
| 2025 Q2-osavuosiraportti | 21.8. | |
| 2024 Yhtiökokous | 15.5. | |
| 2025 Q1-osavuosiraportti | 12.5. |
Datan lähde: Millistream, Quartr
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·3 päivää sitten · MuokattuRHT is a real dark horse right now that can truly become a total game changer for Acarix. The good thing is, as you know, that the application is already complete and an answer is expected by the end of December. Some clipped quotes from the website with information about RHT: "Spark the growth of innovative care models to improve health outcomes" "Foster use of innovative technologies that promote efficient care delivery" "Developing projects that support innovative models of care that include value-based care arrangements" This really fits perfectly with CadScore, which can offer economic & affordable diagnostics specifically for rural areas with lower budgets where cardiologists are often lacking, etc. Quote Aamir: "Fitting to the T, we are the definition of what they are trying to do". I can only agree, it doesn't feel like a long shot but rather that it couldn't be stranger if Acarix doesn't get a piece of that $50 billion pie, which, as mentioned, would truly be perfect timing now that things are really starting to look promising. This, which is just one possibility, combined with Aamir's drive... the stock is ridiculously undervalued!? Perhaps it's not so strange that it has taken a long time to get here, but history has little to do with the future as it looks now.
- ·7.11. · MuokattuHas RHS, which Aamir talks a lot about in the presentation, been discussed here yet? Talk about it fitting Acarix 100% Rural Health Transformation refers to a federal program to revitalize rural healthcare through a $50 billion investment authorized by the One Big Beautiful Bill Act. The program aims to strengthen rural health infrastructure by funding state-designed plans that focus on strategic goals such as improving access to care, developing the healthcare workforce, promoting innovation and preventative health, and expanding technology. States submitted applications to the Centers for Medicare & Medicaid Services (CMS) for funding, with the application period closing on November 5, 2025. Awards are expected to be announced by December 31, 2025.
- ·6.11. · MuokattuAamir works extremely hard with 100% commitment and seems to be doing most things right, while also being heavily invested in the company himself. If it continues in the right direction at this pace, this will turn out really well quite soon. With halved cash burn and increasing revenues, liquid funds will last until mid-2026, and just as Aamir says, this ensures that potential new financing can be arranged then with good terms. The Rural Health Grant also sounds clearly interesting and is truly a perfect match for Casdscore. I find it hard to understand today's mild reaction!·7.11. · MuokattuI have three points: 1) The Q2 report was probably not very good - at least not financially. Many investors may be concerned that the Q3 figures are a one-off driven by MENA sales, and will want to see more consistency before they truly enter the case. 2) Concerns about further dilution in 2026 and/or new costs related to the new innovations Acarix is working on. 3) Financial reports are pouring out these days - including major market fluctuations. Acarix is probably not a top priority in many places, so maybe things just need to settle down? I can certainly say yes to all three points - I just need to figure out if now is the time to put more money into Acarix.·7.11.1. Nothing says that MENA cannot increase both in the short and long term. 22 new CS in the USA in just one quarter is certainly not to be underestimated. 2. There are currently approximately 21 MSEK in liquid assets. With a cash burn of 2.5-3 MSEK / month, that's enough well into 2026. And if revenues continue to increase on top of that... 3. True, it would be sensible with some AI-Tech bubble money transferred to neglected MedTech now!! Overall, Aamir is really holding onto the money while doing most things right!! It is undoubtedly moving in the right direction.
- ·6.11.Analysis firm Redeye has this comment on today's Q3 report, including that they expect a 5-10 % increase in the share today due to the Q3 result : Acarix (Q3 Initial take): Record sales and improved OPEX Research Note 2025-11-06 08:50 Redeye provides its initial take on Acarix’s Q3 report, which showed record quarterly sales driven by the company’s first order and entry into the MENA region, as well as continued momentum in the US. The company also demonstrated improved cost efficiency following the implementation of its cost-saving initiatives, resulting in OPEX coming in better than our estimates. We expect a positive share price reaction of approximately 5–10% today.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
First North Sweden
Määrä
Osto
1 624
Myynti
Määrä
35 907
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 1 624 | - | - | ||
| 5 000 | - | - | ||
| 13 000 | - | - | ||
| 400 | - | - | ||
| 693 | - | - |
Ylin
0,287VWAP
Alin
0,272VaihtoMäärä
0,1 466 483
VWAP
Ylin
0,287Alin
0,272VaihtoMäärä
0,1 466 483
Välittäjätilasto
Dataa ei löytynyt